EVOK insider transaction filings
Evoke Pharma Inc — 32 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-12-19. Screen EVOK transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-12-19 | 4 | Nantahala Capital Management, LLC — 10% owner Harkey Wilmot B. — 10% owner Mack Daniel — 10% owner | Other (J): 148,153 @ $11 · Other (J): 433,962 (derivative) @ $11.00 · Other (J): 117,019 (derivative) @ $4.71 · Other (J): 117,019 (derivative) @ $4.71 · Other (J): 158,531 (derivative) @ $10.99 · Other (J): 250,627 (derivative) @ $10.99 | EDGAR |
| 2025-12-17 | 4 | PYSZCZYMUKA GREG — Director | Disposition to issuer (D): 5,833 (derivative) · Disposition to issuer (D): 1,155 (derivative) | EDGAR |
| 2025-12-17 | 4 | Smeal Benjamin C. — Director | Disposition to issuer (D): 5,833 (derivative) · Disposition to issuer (D): 1,125 (derivative) | EDGAR |
| 2025-12-17 | 4 | CARLSON MARILYN R. — Chief Medical Officer | Code (U): 360 · Disposition to issuer (D): 17,291 (derivative) · Disposition to issuer (D): 11,000 (derivative) | EDGAR |
| 2025-12-17 | 4 | Hill Malcolm R — Director | Code (U): 133 · Disposition to issuer (D): 1,218 (derivative) · Disposition to issuer (D): 5,833 (derivative) · Disposition to issuer (D): 1,218 (derivative) | EDGAR |
| 2025-12-17 | 4 | Kowieski Mark — Chief Financial Officer | Code (U): 11,815 · Disposition to issuer (D): 17,291 (derivative) · Disposition to issuer (D): 13,000 (derivative) | EDGAR |
| 2025-12-17 | 4 | Brady Todd C — Director | Code (U): 27 · Disposition to issuer (D): 1,218 (derivative) · Disposition to issuer (D): 5,833 (derivative) · Disposition to issuer (D): 1,187 (derivative) | EDGAR |
| 2025-12-17 | 4 | REED VICKIE S — Director | Disposition to issuer (D): 1,250 (derivative) · Disposition to issuer (D): 5,833 (derivative) · Disposition to issuer (D): 1,250 (derivative) | EDGAR |
| 2025-12-17 | 4 | D'Onofrio Matthew J — Chief Executive Officer, Director | Code (U): 15,509 · Disposition to issuer (D): 64,840 (derivative) · Disposition to issuer (D): 70,000 (derivative) | EDGAR |
| 2025-12-17 | 4 | WIDDER KENNETH J — Director | Disposition to issuer (D): 1,187 (derivative) · Disposition to issuer (D): 5,833 (derivative) · Disposition to issuer (D): 1,187 (derivative) | EDGAR |
| 2025-12-17 | 4 | GARNER CAM L — Director | Code (U): 2,330 · Disposition to issuer (D): 1,479 (derivative) · Disposition to issuer (D): 8,750 (derivative) · Disposition to issuer (D): 1,291 (derivative) | EDGAR |
| 2025-11-07 | 4 | Klein Roger M. — 10% owner | Sale (S): 5,000 @ $10.66 · Sale (S): 4,000 @ $10.65 | EDGAR |
| 2025-05-22 | 4 | Brady Todd C — Director | Grant/award (A): 1,187 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | Hill Malcolm R — Director | Grant/award (A): 1,218 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | REED VICKIE S — Director | Grant/award (A): 1,250 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | Smeal Benjamin C. — Director | Grant/award (A): 1,125 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | PYSZCZYMUKA GREG — Director | Grant/award (A): 1,155 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | WIDDER KENNETH J — Director | Grant/award (A): 1,187 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | GARNER CAM L — Director | Grant/award (A): 1,291 (derivative) @ $0 | EDGAR |
| 2025-03-24 | 4 | D'Onofrio Matthew J — Chief Executive Officer, Director | Grant/award (A): 1,000 @ $2.80 | EDGAR |
| 2025-03-24 | 4 | Kowieski Mark — Chief Financial Officer | Grant/award (A): 4,500 @ $3.21 | EDGAR |
| 2025-03-03 | 4 | D'Onofrio Matthew J — Chief Executive Officer, Director | Grant/award (A): 6,849 @ $3.65 | EDGAR |
| 2025-02-24 | 4 | PYSZCZYMUKA GREG — Director | Grant/award (A): 5,833 (derivative) @ $0 | EDGAR |
| 2025-01-30 | 4 | Nantahala Capital Management, LLC — 10% owner Harkey Wilmot B. — 10% owner Mack Daniel — 10% owner | Sale (S): 41 @ $4.39 | EDGAR |
| 2025-01-29 | 4 | Hill Malcolm R — Director | Grant/award (A): 5,833 (derivative) @ $0 | EDGAR |
| 2025-01-29 | 4 | Kowieski Mark — Chief Financial Officer | Grant/award (A): 13,000 (derivative) @ $0 | EDGAR |
| 2025-01-29 | 4 | CARLSON MARILYN R. — Chief Medical Officer | Grant/award (A): 11,000 (derivative) @ $0 | EDGAR |
| 2025-01-29 | 4 | D'Onofrio Matthew J — Chief Executive Officer, Director | Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2025-01-29 | 4 | REED VICKIE S — Director | Grant/award (A): 5,833 (derivative) @ $0 | EDGAR |
| 2025-01-29 | 4 | Brady Todd C — Director | Grant/award (A): 5,833 (derivative) @ $0 | EDGAR |
| 2025-01-29 | 4 | WIDDER KENNETH J — Director | Grant/award (A): 5,833 (derivative) @ $0 | EDGAR |
| 2025-01-29 | 4 | GARNER CAM L — Director | Grant/award (A): 8,750 (derivative) @ $0 | EDGAR |
Recent 8-K events — Evoke Pharma Inc
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-12-17 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-04 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-06 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-07-09 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-05-22 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-05-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-13 | 8-K | 2.02 — Results of Operations and Financial Condition | EDGAR |
| 2025-02-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=EVOK returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →